No abstract available
MeSH terms
-
Adverse Drug Reaction Reporting Systems
-
Alanine Transaminase / blood
-
Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
-
Anticoagulants / adverse effects*
-
Azetidines / adverse effects*
-
Benzophenones / adverse effects*
-
Benzylamines / adverse effects*
-
Bilirubin / blood
-
Biomarkers / blood
-
Bromobenzenes / adverse effects*
-
Chemical and Drug Induced Liver Injury / blood
-
Chemical and Drug Induced Liver Injury / enzymology
-
Chemical and Drug Induced Liver Injury / etiology*
-
Chromans / adverse effects*
-
Drug Approval
-
Humans
-
Hypoglycemic Agents / adverse effects*
-
Liver / drug effects*
-
Liver / enzymology
-
Predictive Value of Tests
-
Randomized Controlled Trials as Topic
-
Risk Assessment
-
Thiazolidinediones / adverse effects*
-
Troglitazone
-
United States
-
United States Food and Drug Administration
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Anticoagulants
-
Azetidines
-
Benzophenones
-
Benzylamines
-
Biomarkers
-
Bromobenzenes
-
Chromans
-
Hypoglycemic Agents
-
Thiazolidinediones
-
ximelagatran
-
bromfenac
-
Alanine Transaminase
-
Troglitazone
-
Bilirubin